Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
The Burden of Hypercoagulability in COVID-19
Madeleine Kim1, Andrew George2, Latha Ganti3
1The Baylor School, Chatanooga, Tennessee, United States.
Insights
Recent COVID-19 infection can cause severe blood clots, including deep vein thrombosis and pulmonary embolism. This case report highlights the link between SARS-CoV-2 and hypercoagulability, discussing potential mechanisms and patient management.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Hematology
Background:
- COVID-19, caused by SARS-CoV-2, affects multiple organ systems, notably endothelial cells.
- Endothelial damage can occur through direct viral interaction or indirect inflammatory responses (cytokine storms).
- This damage disrupts the balance between pro-thrombotic and anti-thrombotic factors, increasing clotting risk.
Observation:
- A case of a patient with extensive deep vein thrombosis and pulmonary embolism is presented.
- The patient had a recent history of COVID-19 infection.
- This clinical presentation suggests a link between SARS-CoV-2 infection and severe thrombotic events.
Findings:
- COVID-19 infection leads to endothelial dysfunction, characterized by increased thrombotic factor release and impaired fibrinolysis.
- This results in a state of hypercoagulability in infected or recovering individuals.
- The case illustrates a severe manifestation of COVID-19-associated coagulopathy.
Implications:
- Understanding the mechanisms of COVID-19-induced hypercoagulability is crucial for patient management.
- Early recognition and appropriate anticoagulation strategies may be vital for patients with recent SARS-CoV-2 infection.
- Further research into the direct and indirect pathways of endothelial damage is warranted to refine treatment protocols.
Abstract:
The novel coronavirus disease 2019 (COVID-19) infection has widespread impact on multiple organ systems, including damage to endothelial cells. Various studies have found evidence for direct mechanisms by which interaction between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and endothelial cells lead to extensive damage to the latter, and indirect mechanisms, such as excessively elevated cytokines, can also result in the same outcome. Damage to the endothelium results in release of thrombotic factors and inhibition of fibrinolysis. This confers a significant hypercoagulability burden on patients infected or recovering from COVID-19 infection. In this case report, the authors report the case of a gentleman presenting with extensive deep vein thrombosis and pulmonary embolism, in the context of recent COVID-19 infection. The postulated mechanisms and management are discussed.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care

